Cannabis firm Cronos inks $122 million deal to produce lab-grown cannabinoids
Canadian cannabis producer Cronos Group has tapped Boston-based Ginkgo Bioworks in a $122 million endeavor to biologically engineer a wide range of cannabinoids found in cannabis. Under the deal, announced Tuesday, Ginkgo, which creates customized microbes, will work exclusively with Cronos to research and design microorganisms capable of producing cannabinoids. AccordingContinue Reading